ImmunoMet ImmunoMet is a clinical-stage biotechnological company that specializes in tumor metabolism and immuno-metabolism. | ![]() Fennec Pharma Fennec Pharmaceuticals is a biotechnology company focused on the development of Sodium Thiosulfate for the prevention of ototoxicity from cisplatin in pediatric patients. | ![]() Rasna Therapeutics Rasna Therapeutics focusses on development therapeutics to address the high unmet need that exists for AML and other forms of leukemia. | |
Founding Date | Founding Date 2015 | Founding Date 1996 | Founding Date 2013 |
Type | Type Private | Type Public | Type Public |
Tags | |||
Locations | Locations Houston, US HQ | Locations US HQ | Locations New York, US HQ Greater London, GB Doylestown, US |
Employees | Employees 814% increase | Employees 433% increase | Employees N/A |
Valuation ($) | Valuation ($) N/A | Valuation ($) 129.4 m | Valuation ($) 3.1 m |
Financial | |||
Net income | Net income N/A | Net income ($9.7m) (FY, 2025) | Net income ($4.4m) (FY, 2023) |

Fennec Pharmaceuticals is a biotechnology company focused on the development of Sodium Thiosulfate for the prevention of ototoxicity from cisplatin in pediatric patients.
View company
Rasna Therapeutics focusses on development therapeutics to address the high unmet need that exists for AML and other forms of leukemia.
View company